Senrex
with its refusal to provide the AASLD data to shareholders, its general reduction of Bavi’s scope...."
Some of us requested a copy of the actual abstract that was presented at AASLD. The 8 X 10 or the 11 x 14 copy, complete with graphs,color pics etc...IR did not release those, nor is it posted on the website. Most small cap biotechs send out the actual hard copy abstracts when a simple IR package is requested.
Twelve weeks has passed since the last patient cohort was dosed in the Phase Ib repeat dose study. I, and others await 'top-line' data which is according to my arithmetic, overdue. Perhaps PPHM will release that data this week. It's due.
katie....